PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30175228-5	2018	A significant interaction was observed between treatment and the APOE genotype on AD progression: epsilon4 carriers declined faster than noncarriers in the vitamin E plus memantine treatment arm.	Memantine	171-180	apolipoprotein E	Homo sapiens	65-69	
25376930-7	2015	CONCLUSION: The BCHE-K genotype may be related to a poor cognitive response to rivastigmine patch or memantine add-on therapy, especially in the presence of apolipoprotein E epsilon 4.	Memantine	101-110	apolipoprotein E	Homo sapiens	157-183	
23051684-0	2012	Response to rivastigmine transdermal patch or memantine plus rivastigmine patch is affected by apolipoprotein E genotype in Alzheimer patients.	Memantine	46-55	apolipoprotein E	Homo sapiens	95-111	
23051684-7	2012	CONCLUSION: Moderately severe AD patients with the APOE epsilon4 allele may respond more favorably to memantine plus rivastigmine patch than epsilon4 noncarriers.	Memantine	102-111	apolipoprotein E	Homo sapiens	51-55